Novo Nordisk enters into collaboration with Danish crispr firm Snipr

The small Danish biotech company Snipr Biome, which uses crispr technology, has landed its first partnership.

Photo: Novo Nordisk / PR

Shortly after Snipr Biome managed to bring in new money through its first non-commercial partnership with antimicrobial alliance Carb-X, the Danish company has now managed to find its first commercial partner.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs